Bionano Genomics Inc (BNGO)
0.2214
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 11:58
Bionano Genomics Profit Margin (Quarterly): -728.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -728.6% |
| June 30, 2024 | -208.8% |
| March 31, 2024 | -358.3% |
| December 31, 2023 | -409.4% |
| September 30, 2023 | -1.21K% |
| June 30, 2023 | -449.2% |
| March 31, 2023 | -500.7% |
| December 31, 2022 | -470.8% |
| September 30, 2022 | -440.5% |
| June 30, 2022 | -482.1% |
| March 31, 2022 | -525.8% |
| December 31, 2021 | -364.2% |
| September 30, 2021 | -445.8% |
| June 30, 2021 | -487.2% |
| March 31, 2021 | -314.0% |
| December 31, 2020 | -294.0% |
| Date | Value |
|---|---|
| September 30, 2020 | -491.4% |
| June 30, 2020 | -683.1% |
| March 31, 2020 | -925.2% |
| December 31, 2019 | -283.2% |
| September 30, 2019 | -193.1% |
| June 30, 2019 | -352.4% |
| March 31, 2019 | -423.7% |
| December 31, 2018 | -159.7% |
| September 30, 2018 | -174.1% |
| June 30, 2018 | -97.68% |
| March 31, 2018 | -217.6% |
| December 31, 2017 | -208.1% |
| September 30, 2017 | -185.4% |
| June 30, 2017 | -303.9% |
| March 31, 2017 | -330.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.21K%
Minimum
Sep 2023
-208.8%
Maximum
Jun 2024
-503.5%
Average
-460.0%
Median
Profit Margin (Quarterly) Benchmarks
| Revvity Inc | 13.80% |
| Bruker Corp | 4.73% |
| Azenta Inc | -2.93% |
| Harvard Bioscience Inc | -21.86% |
| Akoya Biosciences Inc | -55.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -158.9% |
| Return on Assets | -88.05% |
| Return on Invested Capital | -121.2% |
| Gross Profit Margin (Quarterly) | -139.1% |
| Operating Margin (Quarterly) | -372.6% |
| Return on Net Operating Assets | -153.0% |